FDA Clears AI-Powered Cardiovascular Ultrasound System from Siemens Healthineers
Offering a variety of AI features for streamlined workflow and enhanced visualization, the Acuson Origin ultrasound system also features the newly FDA-cleared AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter.
The Food and Drug Administration (FDA) has granted 510(k) clearance for the Acuson Origin cardiovascular ultrasound system and the accompanying AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter.
The Acuson Origin system reportedly bolsters workflow efficiency for transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) with over 5,600 artificial intelligence (AI) automated measurements, according to Siemens Healthineers, the manufacturer of the device.
The Acuson Origin ultrasound system reportedly bolsters workflow efficiency for transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) with over 5,600 artificial intelligence (AI ) automated measurements, according to Siemens Healthineers, the manufacturer of the device. (Image courtesy of Siemens Healthineers.)
AI Assist, one of the new TTE features for the Acuson Origin, provides automated positioning of color and spectral Doppler regions of interest. Offering real-time cardiac view recognition, Siemens Healthineers said the 4D HeartAI feature has a 98 percent accuracy for the identification and alignment of multiplanar reconstruction (MPR).
“With its advanced AI features and potential to enhance diagnostic accuracy as well as patient care, the Acuson Origin is positioned to reshape health care’s approach to cardiovascular imaging,” noted David Zollinger, the head of cardiovascular ultrasound at Siemens Healthineers.
Providing advanced imaging for complex heart procedures, Siemens Healthineers noted the AcuNav Lumos catheter promotes enhanced accuracy of anatomical assessments with MPR biplane imaging. The device’s real-time 4D color Doppler capabilities also facilitate improved leak detection, according to Siemens Healthineers.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
